This Episode examine the complex regulatory, health, and environmental landscape of the global cosmetics industry. Authors highlight a significant regulatory divide between the European Union’s strict bans and the United States’ evolving framework under MoCRA, which aims to enhance FDA oversight and product safety. Central to the discussion are the risks of toxic ingredients, such as heavy metals and endocrine disruptors, contrasted with the instability of preservative-free "clean beauty" products that may succumb to mold or bacterial growth. Documentation of product recalls and life cycle assessments further illustrates the industry's ecological footprint, including microplastic pollution and resource-intensive manufacturing. Ad ...